Effect of glycosaminoglycans on urinary albumin excretion in insulin- dependent diabetic patients with micro- or macroalbuminuria

Diabetes Research and Clinical Practice

Volumn 38, Issue 2, 1997, Pages 109-114

  Poplawska, A ^a   Szelachowska, M ^a   Topolska, J ^a   Wysocka Solowie, B ^a   Kinalska, I ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Diabetic nephropathy; Glycosaminoglycans; Sulodexide; Urinary albumin excretion rate

Indexed keywords

GLYCOSAMINOGLYCAN; SULODEXIDE;

ADULT; ARTICLE; CELL GROWTH; CLINICAL ARTICLE; DIABETIC NEPHROPATHY; DRUG EFFECT; EPITHELIUM CELL; EXTRACELLULAR MATRIX; FEMALE; GLOMERULUS BASEMENT MEMBRANE; GLYCOSYLATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; ORAL DRUG ADMINISTRATION; PROTEINURIA; RISK FACTOR; URINARY EXCRETION;

ADOLESCENT; ADULT; ALBUMINURIA; DIABETES MELLITUS, TYPE 1; FEMALE; GLYCOSAMINOGLYCANS; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; REFERENCE VALUES; TIME FACTORS; TREATMENT OUTCOME;

EID: 0031408776     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8227(97)00096-X     Document Type: Article

References (12)

1. Almdal T., Norgaard K., Feldt-Rasmussen B., Deckert T. The predictive value of microalbuminuria in IDDM. Diabetes Care. 17:1994;120-125.
2. Deckert T., Feldt-Rasmussen B., Djurup R., Deckert M. Glomerular size and charge selectivity in insulin-dependent diabetes mellitus. Kidney Int. 33:1988;100-106.
3. Gambaro G., Baggio B. Role of glycosaminoglycans in diabetic nephropathy. Acta Diabetol. 29:1992;149-155.
4. Gambaro G., Venturini A.P., Noonan D.M., Fries W., Re G., Garbisa S., Milanesi C., Pesarini A., Borsatti A., Marchi E., Baggio B. Treatment with a glycosaminoglycan formulation ameliorates experimental diabetic nephropathy. Kidney Int. 46:1994;797-806.
5. Solini A., Carraro A., Barzon I., Crepaldi G. Therapy with glycosaminoglycans lowers albumin excretion rate in non-insulin dependent diabetic patients with macroalbuminuria. Diabetes Nutr. Metab. 7:1994;304-307.
6. Myrup B., Hansen P.M., Jensen T., Kofoed-Enevoldsen A., Feldt-Rasmussen B., Gram J., Kluft C., Jespersen J., Deckert T. Effect of low-dose heparin on urinary albumin excretion in insulin-dependent diabetes mellitus. Lancet. 345:1995;421-422.
7. Tamsma J.T., van der Woude F.J., Lemkes H.H.P.J. Effect of sulphated glycosaminoglycans on albuminuria in patients with overt diabetic (type I) nephropathy. Nephrol. Dial. Transplant. 11:1996;182-185.
8. Szelachowska M., Poplawska A., Topolska J., Kinalska I., Grimaldi M. A pilot study of the effect of the glycosaminoglycan on microalbuminuria in type I diabetic patients. Curr. Med. Res. Opin. 13(9):1997;539-545.
9. Solini A., Vergnani L., Ricci F., Crepaldi G. Glycosaminoglycans delay the progression of nephropathy in NIDDM. Diabetes Care. 20(5):1994;813-817.
10. E.D. Schleicher, Biochemical aspects of diabetic nephropathy, in: C.E. Mogensen (Ed.), The Kidney and Hypertension in Diabetes Mellitus, Kluwer Academic Publishers, Boston, (1994), pp. 191-202.
11. Gambaro G., Venturini A.P., Barbanti M., Nassuato M.A., Bertaglia G., Baggio B. Urinary excretion of glycosaminoglycans and albumin in experimental diabetes. Contrib. Nephrol. 101:1993;109-113.
12. Baggio B., Briani G., Cicerello E., Gambaro G., Bruttomesso D., Tiengo A., Borsatti A., Crepaldi G. Urinary glycosaminoglycans, sialic acid and lysosomal enzymes increase in nonalbuminuric diabetic patients. Nephron. 43:1986;187-190.